Italia markets closed

Absci Corporation (ABSI)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
4,6150-0,1250 (-2,64%)
Alla chiusura: 04:00PM EDT
4,6000 -0,01 (-0,33%)
Dopo ore: 07:52PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente4,7400
Aperto4,7500
Denaro4,6000 x 200
Lettera4,6600 x 100
Min-Max giorno4,5800 - 4,7500
Intervallo di 52 settimane1,1110 - 6,7200
Volume545.040
Media Volume1.328.531
Capitalizzazione521,883M
Beta (5 anni mensile)2,39
Rapporto PE (ttm)N/D
EPS (ttm)-1,2000
Prossima data utili12 ago 2024 - 16 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A8,60
  • GlobeNewswire

    Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

    VANCOUVER, Wash. and NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the speaker lineup for its inaugural R&D Day on Wednesday, October 4th, 2023. The program will begin at 9:00 a.m. Eastern Time and feature presentations from: Sean McClain, Founder & CEOZach Jonasson, Ph.D., Chief Financial Officer & Chief Business OfficerAndreas Busch, Ph.D., Chief Innovation OfficerAmaro Taylor-Weiner, Ph.D., Chief AI Office

  • GlobeNewswire

    Absci to Host R&D Day on October 4, 2023

    VANCOUVER, Wash. and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will host its first R&D Day on Wednesday, October 4th, 2023 in New York City. The program will begin at 9:00 a.m. Eastern Time and feature presentations from members of Absci’s leadership team as well as guest speakers, followed by an interactive Q&A session. The program is expected to conclude at approximately 12:00 p.m. Eastern T

  • GlobeNewswire

    Absci to Participate in Upcoming Investor Conferences

    VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. Wainwright 25th Annual Global Investment ConferenceFireside chat on Monday, September 11th at 2:00 p.m. Eastern Time Morgan Stanley 21st Annual Global Healthcare ConferenceFireside chat on Wednesday, September 13th at 4:55 p.m. Eastern Time 2023 Cantor Fitzge